Skip to content
Pharma Modern Data

Modern pharmaceutical data, structured for cross-country decisions.

Pharma Modern Data is building a standardisation and update engine that collects official medicine information across countries and restructures it into a comparable, decision-ready dataset.

RSALIMS - Registar lekovaHTML

Amoksicilin · kaps. tvrda, 500 mg · blister, 16 kom

HRHALMED - Baza lijekovaXLSX

AMOKSICILIN CAPS 500MG×16 · cijena 3,10 EUR

GREOF - Δελτίο ΤιμώνPDF

ΑΜΟΞΙΚΙΛΛΙΝΗ 500MG/CAP BTx16 · 2,86 €

pmd:recordvalidated ✓

Amoxicillin

500 mg hard capsule - pack of 16

INN
amoxicillin
ATC
J01CA04
Form
capsule
Strength
500 mg
Pack
16 units
Markets
RS · HR · GR
id amx-500-cap-16source-linked ✓updated 2026-07v3

From fragmented official sources - to one standardised, source-linked record.

Official data · Standardised structure · Better decisions

The problem

Available, but rarely comparable.

PDF bulletinsSpreadsheetsOnline registriesNational databasesOfficial gazettes

Across countries, medicine data is published in different formats, languages, identifiers and update cycles. Comparing markets means manual reconciliation - slow, expensive and hard to audit.

Our solution

Built around four principles.

Standardisation
Country-specific data is mapped into one common structure, comparable across markets.
Traceability
Fields link back to the official sources they came from, wherever possible.
Update discipline
Monitored sources, structured refresh cycles, change logs and versioning - not a static database.
Practical usability
Designed for real workflows: market screening, pricing comparison, reimbursement review and reporting.

Who PMD supports

For teams that reconcile pharmaceutical data by hand today.

Manufacturers and Marketing Authorisation Holders, market access and pricing teams, commercial operations, distributors, consultancies and business intelligence teams working across multiple markets.

Get in touch

Building the standardisation layer for pharmaceutical intelligence.

Business enquiries, partnerships and investment-related communication are welcome while the platform is in development.

Contact PMD